Researchers Want To Make India Nanotech Drugs Center
This article was originally published in PharmAsia News
A pair of Indian researchers is embarked on a venture to develop nanotechnology drugs, creating a new pharmaceutical industry in India. Kattesh Katti and Raghuraman Kannan, currently researchers at a U.S. university, envision a nanomedicine institution in India to develop the technology. One Indian expert suggests Maharashtra and Tamil Nadu as the prime locations for such an institution. (Click here for more
You may also be interested in...
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?